You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Lymphoma, B-Cell, Marginal Zone

Showing 51 - 75 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Follicular Lymphoma and Marginal Zone Lymphoma Trial in Beijing (Recombinant Humanized Monoclonal Antibody MIL62, lenalinomide,

Recruiting
  • Follicular Lymphoma and Marginal Zone Lymphoma
  • Recombinant Humanized Monoclonal Antibody MIL62, lenalinomide
  • lenalinomide
  • Beijing, China
    Chinese Academy of Medical Sciences and Peking Union Medical Col
Feb 13, 2022

Ann Arbor Stage II Follicular Lymphoma, Ann Arbor Stage II Marginal Zone Lymphoma, Ann Arbor Stage III Follicular Lymphoma Trial

Active, not recruiting
  • Ann Arbor Stage II Follicular Lymphoma
  • +9 more
  • Houston, Texas
    M D Anderson Cancer Center
Feb 3, 2022

Extranodal Lymphoma or Lymphoma of Rare Pathological Types

Not yet recruiting
  • Lymphoma
  • +8 more
  • No interventions need to be specified for this study
  • Shanghai, China
    Ruijin Hospital, Shanghai Jiao Tong University School of Medicin
Jun 15, 2023

Ocular Adnexal Mucosa-Associated Lymphoid Tissue Lymphoma Trial in Milano (intralesional rituximab, supplemental autologous

Completed
  • Ocular Adnexal Mucosa-Associated Lymphoid Tissue Lymphoma
  • intralesional rituximab
  • supplemental autologous serum
  • Milano, Italy
    Dip. Oncoematologia - Fondazione Centro San Raffaele del Monte T
Aug 2, 2022

B-cell Chronic Lymphoid Malignancies Markers

Recruiting
  • Chronic Lymphocytic Leukemia
  • +5 more
    • Strasbourg, France
      Hematology Laboratory - Strasbourg University Hospitals
    Jul 2, 2021

    Follicular Lymphoma, Diffuse Large B Cell Lymphoma, Marginal Zone Lymphoma Trial in France (Atezolizumab, Obinutuzumab,

    Completed
    • Follicular Lymphoma
    • +3 more
    • Angers, France
    • +24 more
    Jan 9, 2023

    Marginal Zone Lymphoma, Nodal Marginal Zone Lymphoma, Splenic Marginal Zone Lymphoma Trial in Worldwide (Ibrutinib, Rituximab)

    Recruiting
    • Marginal Zone Lymphoma
    • +2 more
    • Yvoir, Belgium
    • +36 more
    Nov 4, 2022

    Marginal Zone Lymphoma Trial in Zhengzhou (Bortezomib, Rituximab, Epirubicin)

    Recruiting
    • Marginal Zone Lymphoma
    • Zhengzhou, Henan, China
      Henan Cancer Hospital/The affiliated Cancer Hospital of ZhengZho
    Aug 15, 2021

    (CHANT)Real World Study of Duvelisib in Treatment of

    Not yet recruiting
    • Follicular Lymphoma
    • +5 more
    • (no location specified)
    Jun 20, 2023

    Integrated Molecular and Clinical Profiling to Optimize Outcome

    Completed
    • Splenic Marginal Zone Lymphoma
      • Bellinzona, Switzerland
        IOSI
      Jun 4, 2021

      Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, B-cell Marginal Zone, Lymphoma, Non-Hodgkin Trial in Worldwide (LOXO-338,

      Active, not recruiting
      • Leukemia, Lymphocytic, Chronic, B-Cell
      • +6 more
      • Duarte, California
      • +8 more
      Jan 11, 2023

      Relapsed or Refractory B-cell Lymphoma, Diffuse Large B-cell Lymphoma (DLBCL), Follicular Lymphoma (FL) Trial in Beijing

      Recruiting
      • Relapsed or Refractory B-cell Lymphoma
      • +6 more
      • Beijing, China
        Beijing Cancer Hospital
      Feb 6, 2023

      Ann Arbor Stage I B-Cell Non-Hodgkin Lymphoma, Ann Arbor Stage I Grade 1 Follicular Lymphoma, Ann Arbor Stage I Grade 2

      Active, not recruiting
      • Ann Arbor Stage I B-Cell Non-Hodgkin Lymphoma
      • +22 more
      • External Beam Radiation Therapy
      • Orbital Radiation
      • Houston, Texas
        M D Anderson Cancer Center
      Dec 9, 2022

      B-cell Malignancies Undergoing Treatment With Bruton Tyrosine

      Not yet recruiting
      • Chronic Lymphocytic Leukemia
      • +4 more
      • Non-Interventional Study
      • Rochester, Minnesota
        Mayo Clinic in Rochester
      Nov 22, 2023

      Mantle Cell Lymphoma, Follicular Lymphoma, Splenic Marginal Zone Lymphoma Trial in Chapel Hill (CAR.k.28, Fludarabine,

      Recruiting
      • Mantle Cell Lymphoma
      • +5 more
      • Chapel Hill, North Carolina
        Lineberger Comprehensive Cancer Center at University of North Ca
      Nov 19, 2021

      Non-hodgkin Lymphoma, Relapsed Non-Hodgkin Lymphoma, Refractory Non-Hodgkin Lymphoma Trial in Boston (CD79b-19 CAR T cells,

      Not yet recruiting
      • Non-hodgkin Lymphoma
      • +9 more
      • CD79b-19 CAR T cells
      • +2 more
      • Boston, Massachusetts
        Massachusetts General Hospital
      Sep 6, 2023

      Marginal Zone B-cell Lymphoma Trial in Korea, Republic of (bendamustine plus rituximab)

      Completed
      • Marginal Zone B-cell Lymphoma
      • bendamustine plus rituximab
      • Jeonju, Jeollabuk-do, Korea, Republic of
      • +10 more
      Sep 23, 2021

      Chronic Lymphocytic Leukemia (CLL), Diffuse Large B-cell Lymphoma (DLBCL), Follicular Lymphoma (FL) Trial (Routine care as per

      Not yet recruiting
      • Chronic Lymphocytic Leukemia (CLL)
      • +5 more
      • Routine care as per site standard.
      • (no location specified)
      Sep 15, 2023

      Acute Leukemia, Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia Trial in Minneapolis (HSCT with TBI Regimen, HSCT with

      Recruiting
      • Acute Leukemia
      • +27 more
      • HSCT with TBI Regimen
      • HSCT with Non-TBI Regimen
      • Minneapolis, Minnesota
        Masonic Cancer Center at University of Minnesota
      Apr 12, 2022

      Lymphoma, Non-Hodgkin, Lymphoma, Follicular, Lymphoma, Mantle-Cell Trial in Providence (Rituximab, Bendamustine, Vincristine

      Active, not recruiting
      • Lymphoma, Non-Hodgkin
      • +5 more
      • Providence, Rhode Island
        Rhode Island Hospital and The Miriam Hospital
      Jul 19, 2021

      Non-Hodgkin Lymphoma, Follicular Lymphoma, DLBCL Trial in Australia, Korea, Republic of, United States (IGM-2323)

      Recruiting
      • Non-Hodgkin Lymphoma
      • +4 more
      • Duarte, California
      • +23 more
      Dec 28, 2022

      Recurrent B-Cell Non-Hodgkin Lymphoma, Recurrent Grade 1 Follicular Lymphoma, Recurrent Grade 2 Follicular Lymphoma Trial in

      Recruiting
      • Recurrent B-Cell Non-Hodgkin Lymphoma
      • +13 more
      • Polatuzumab Vedotin
      • +3 more
      • Scottsdale, Arizona
      • +11 more
      Aug 23, 2022

      MALT Lymphoma Trial in France, Italy, Switzerland (Chlorambucil, Rituximab i.v., Rituximab s.c.)

      Active, not recruiting
      • MALT Lymphoma
      • Créteil, France
      • +37 more
      Nov 4, 2022

      B-cell Malignancy, Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial (AS-1763)

      Not yet recruiting
      • B-cell Malignancy
      • +7 more
      • (no location specified)
      Oct 26, 2022

      Follicular Lymphoma, Marginal Zone Lymphoma Trial in Italy, Spain, United States (EO2463, lenalidomide, rituximab)

      Recruiting
      • Follicular Lymphoma
      • Marginal Zone Lymphoma
      • EO2463
      • +2 more
      • Boston, Massachusetts
      • +9 more
      Jul 26, 2022